In conclusion, our integrated approach demonstrates that ASV treatment suppressed TGF‐β1/PI3K/Akt pathway to active FOXO3a, thus to prevents EMT in BLM‐induced pulmonary fibrosis (Figure 7). The gene discussed is FOXO3; the disease is pulmonary fibrosis.